Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma

This article contains data on clinical endpoints (Peak Flow Expiratory Rate, fractional exhaled nitric oxide and total IgE serum levels) and plasma pharmacokinetic parameters concerning the use of the oral CRTh2 antagonist QAW039 (fevipiprant) in mild to moderate asthma patients. Information on expe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Data Brief
Main Authors: Erpenbeck, Veit J., Popov, Todor A., Miller, David, Weinstein, Steven F., Spector, Sheldon, Magnusson, Baldur, Osuntokun, Wande, Goldsmith, Paul, Weiss, Markus, Beier, Jutta
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2016
Teme:
Data Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5021787/
https://ncbi.nlm.nih.gov/pubmed/27656673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dib.2016.08.039
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki